Skip to main content
TipRanks
Go Ultimate75% OFF

Richard Aldrich Insider Profile

11 Followers

Richard Aldrich, Director at Tempest Therapeutics, holds 0.00 shares in Concert Pharma (Ticker: CNCE), holds 136.85K shares in Tempest Therapeutics (Ticker: TPST), holds ― shares in KalVista Pharmaceuticals (Ticker: KALV).

Richard Aldrich's Trading History

CNCE
Concert Pharma
Mar 06, 2023―Uninformative Sell―$0.00
TPST
Tempest Therapeutics
Dec 11, 2018DirectorUninformative Buy―$46.67K
KALV
KalVista Pharmaceuticals
Oct 19, 2017―Informative Buy4.87M―
PTCT
PTC Therapeutics
Jun 10, 2015DirectorUninformative Sell389.59K$0.00
VSTM
Verastem
May 20, 2014DirectorInformative Buy8.37K$5.45M
EPRSQ
Epirus Biopharma
―――$0.00

You May Also Like

Richard Aldrich insider profile FAQ

What is the percentage of profitable transactions made by Richard Aldrich?
The percentage of profitable transactions made by Richard Aldrich is 18%.
What is the average return per transaction made by Richard Aldrich?
The average return per transaction made by Richard Aldrich is -31.90%.
What stocks does Richard Aldrich hold?
Richard Aldrich holds: TPST, KALV, CNCE, PTCT, VSTM, EPRSQ stocks.
What was Richard Aldrich's most profitable transaction?
Richard Aldrich’s most profitable transaction was an Informative Buy of TPST stock on March 11, 2014. The return on the trade was 347.50%.
What is Richard Aldrich's role in Tempest Therapeutics?
Richard Aldrich's role in Tempest Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.